Investigation of Clonal Relationship in Hospital-associated Candida Parapsilosis Isolates

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2024 Nov 29

PMID 39612138

Authors

Mahmut Cem Ergon

Ebru Demiray Gurbuz

Nazli Arslan

Sema Alp

Mine Doluca Dereli

Ayse Aydan Ozkutuk

Affiliations

Soon will be listed here.

Abstract

Purpose: We aimed to investigate the clonal relationship and antifungal susceptibility of C. parapsilosis isolated from hospitalized patients and to determine whether it is due to transmission or not and the spread status of resistant isolates.

Methods: Between January 2017 and June 2019, totally 277 C parapsilosis isolated from blood, urine and catheter samples of adult or pediatric in-patient (intensive care and service) who applied to Mycology laboratory in our hospital were included in the study. All isolates were identified using conventional methods, API 20 C AUX (Biomerieux, France) semi-automated system and confirmed by MALDI-TOF MS Biotyper Smart (Bruker Daltonik GmbH, Germany). Randomly amplified polymorphic DNA (RAPD) PCR method was used for molecular genotyping of isolates. MIC values for fluconazole, anidulafungin and amphotericin B were determined according to the M27-A3 CLSI broth microdilution reference method guideline.

Results: Seven different band patterns (A-G) were detected in 277 isolates by RAPD PCR method. According to the rank order of the isolates, 170 (61.37%) C, 65 (23.47%) A, 18 (6.50%) G, 11 (3.97%) B, six (2.17%) E, two (0.72%) F and one (0.36%) D patterns were determined. When the band patterns of the isolates were evaluated according to the years, it was detected that C pattern continued between 2017 and 2019 and that all isolates continued to spread only as C pattern in 2019. While 211 (76.17%) of the isolates were resistant to fluconazole (≥ 8 µg/ml), two (0.72%) were resistant to amphotericin B (≥ 2 µg/ml) and two (0.72%) were intermediate to anidulafungin.

Conclusions: It is noteworthy that the spread of the C pattern in C. parapsilosis strains has increased over the years and is the main pattern isolated from the whole hospital. The detection of high fluconazole resistance in C. parapsilosis isolates in our hospital may also be related to the dominant pattern.

References

Pharkjaksu S, Chongtrakool P, Suwannakarn K, Ngamskulrungroj P . Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015. Med Mycol. 2017; 56(4):426-433. DOI: 10.1093/mmy/myx058. View

Ge Y, Boekhout T, Zhan P, Lu G, Shen Y, Li M . Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities. Med Mycol. 2011; 50(1):56-66. DOI: 10.3109/13693786.2011.591440. View

Lupetti A, Tavanti A, Davini P, Ghelardi E, Corsini V, Merusi I . Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol. 2002; 40(7):2363-9. PMC: 120610. DOI: 10.1128/JCM.40.7.2363-2369.2002. View

Lovero G, Borghi E, Balbino S, Cirasola D, De Giglio O, Perdoni F . Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014. PLoS One. 2016; 11(2):e0150218. PMC: 4769087. DOI: 10.1371/journal.pone.0150218. View

Daneshnia F, de Almeida Junior J, Ilkit M, Lombardi L, Perry A, Gao M . Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe. 2023; 4(6):e470-e480. PMC: 10634418. DOI: 10.1016/S2666-5247(23)00067-8. View

Pristov K, Ghannoum M . Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019; 25(7):792-798. DOI: 10.1016/j.cmi.2019.03.028. View

Hernandez-Castro R, Arroyo-Escalante S, Carrillo-Casas E, Moncada-Barron D, Alvarez-Verona E, Hernandez-Delgado L . Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers source. Eur J Pediatr. 2009; 169(7):783-7. DOI: 10.1007/s00431-009-1109-7. View

Dassanayake R, Samaranayake L . Characterization of the genetic diversity in superficial and systemic human isolates of Candida parapsilosis by randomly amplified polymorphic DNA (RAPD). APMIS. 2000; 108(2):153-60. DOI: 10.1034/j.1600-0463.2000.d01-39.x. View

Tay S, Na S, Chong J . Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J Med Microbiol. 2009; 58(Pt 2):185-191. DOI: 10.1099/jmm.0.004242-0. View

10.

Rocha B, Del Negro G, Yamamoto L, Souza M, Precioso A, Okay T . Identification and differentiation of Candida species from pediatric patients by random amplified polymorphic DNA. Rev Soc Bras Med Trop. 2008; 41(1):1-5. DOI: 10.1590/s0037-86822008000100001. View

11.

Gultekin B, Eyigor M, Tiryaki Y, Kirdar S, Aydin N . [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR]. Mikrobiyol Bul. 2011; 45(2):306-17. View

12.

Kuzucu C, Durmaz R, Otlu B, Aktas E, Gulcan H, Cizmeci Z . Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol. 2008; 31(3):401-8. View

13.

Ergon M, Gulay Z . Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Mycoses. 2005; 48(2):126-31. DOI: 10.1111/j.1439-0507.2004.01086.x. View

14.

Valerio H, Weikert-Oliveira R, de Resende M . Differentiation of Candida species obtained from nosocomial candidemia using RAPD-PCR technique. Rev Soc Bras Med Trop. 2006; 39(2):174-8. DOI: 10.1590/s0037-86822006000200008. View

15.

Chassot F, Venturini T, Piasentin F, Santurio J, Svidzinski T, Alves S . Activity of antifungal agents alone and in combination against echinocandin-susceptible and -resistant Candida parapsilosis strains. Rev Iberoam Micol. 2019; 36(1):44-47. DOI: 10.1016/j.riam.2018.07.007. View

16.

Mesini A, Mikulska M, Giacobbe D, Del Puente F, Gandolfo N, Codda G . Changing epidemiology of candidaemia: Increase in fluconazole-resistant Candida parapsilosis. Mycoses. 2020; 63(4):361-368. DOI: 10.1111/myc.13050. View

17.

Forrest G, Weekes E, Johnson J . Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect. 2007; 56(2):126-9. DOI: 10.1016/j.jinf.2007.10.014. View